insights_auto
Why is EDIT down 3,39%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,71 $
arrow_downward
-3,39%(-0,060) 1D
1,74 $
arrow_upward
+1,75% (+0,030)bedtimeAfter hours
Closed: 19 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,80 $
High
1,83 $
Low
1,70 $
Mkt. cap
263,92 մլն
Avg. vol.
2,38 մլն
Volume
1,93 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,80 $
High
1,83 $
Low
1,70 $
Mkt. cap
263,92 մլն
Avg. vol.
2,38 մլն
Volume
1,93 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
Yahoo Finance
·
53 րոպե առաջ
S&P 500, Nasdaq, Dow End Lower As Anthropic Trading Debut Fails To Provide Adequate Confidence — ANT, META, AAPL, GME In Focus
Traders Union
·
1 ժամ առաջ
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
ChartMill
·
1 ժամ առաջ
S&P 500 After-Hours Movers: Nov. 19, 2026
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc